Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer

OMP, derived from routine CT examination, could serve as a non-invasive and cost-effective biomarker to predict NSCLC patient response to immune checkpoint inhibitor-based therapy. OMP could be used alone or in combination with other biomarkers to improve precision immunotherapy.

Authors

Institutions

Publication Details

Journal
BMJ Oncology
Published
2024-08-01
DOI
https://doi.org/10.1136/bmjonc-2024-000473
Citations
4
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.13

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer

Liang Sun, Hongtai Shi, Jiya Sun, Rakesh K. Jain et al.
4 citations
BMJ Oncology
Cancer Immunotherapy and Biomarkers
1.13
article

Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer

Liang Sun, Hongtai Shi, Jiya Sun, Rakesh K. Jain, Junhui Wang, Bo Zhu, Qingzhu Jia, Yuhui Huang, Yunpeng Yang, Ying Wang, Zhenhua Liu, Li Zhang, Peng Fan, Songbing Qin, Ke Ma, Wei Xu, Liansai Sun
article en
4 citations

Abstract

OMP, derived from routine CT examination, could serve as a non-invasive and cost-effective biomarker to predict NSCLC patient response to immune checkpoint inhibitor-based therapy. OMP could be used alone or in combination with other biomarkers to improve precision immunotherapy.

BMJ OncologyVol. 3(1)
Harvard University (US), Army Medical University (CN), Sun Yat-sen University (CN), Nantong University (CN), Soochow University (CN), Massachusetts General Hospital (US), Yancheng First People's Hospital (CN), Yancheng Third People's Hospital (CN), Sun Yat-sen University Cancer Center (CN), First Affiliated Hospital of Soochow University (CN), Innovative Biologics (United States) (US)
National Foundation for Cancer Research, Advanced Medical Research Foundation, National Natural Science Foundation of China, Soochow University, Priority Academic Program Development of Jiangsu Higher Education Institutions
Good health and well-being
Openalex Percentile: Top 19%
Cancer Immunotherapy and Biomarkers
1.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.